Trimedyne, Inc. reported earnings results for the fiscal year ended on September 30, 2017. For the fiscal year, the company’s Revenue was $4,695,000, a decrease of 8% from revenues of $5,109,000 for the prior year. Net loss was $44,000 or $0.36 per share as compared to a net loss of $536,000 or $4.37 per share for the prior fiscal year, adjusted for a 150 to one reverse stock split in November, 2016. This 92% decrease in net loss as compared to the prior fiscal year.